Perspective · 19 Mar 2025
Short communicationPublished 2016
Immunogenetherapy of Cancer Using Recombinant Adenovirus Expressing Type III interferon IL-28A or IL-29
Subjects
Immunology & MicrobiologyMore from this journal
The newest in Immunotherapy: Open Access.
Perspective · 19 Mar 2025
Advancing Immunotherapy: Future Directions in the Fight against Renal Cell Carcinoma
Short communication · 19 Mar 2025
Emerging Therapies: The Latest Developments in Autoimmune Disease Management
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunotherapy: Open Access
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Muneo Numasaki”
- BylineArticles whose byline prints “Masatoshi Tagawa”
- BylineArticles whose byline prints “Hiroki Tsukamoto”
- BylineArticles whose byline prints “Yoshihisa Tomioka”
- BylineArticles whose byline prints “Takashi Ohrui”
- BylineArticles whose byline prints “Hiroyuki Arai”
